Finanzen von DocGo Inc (DCGO)DCGODocGo Inc

DocGo Inc. (DCGO) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Transportation Services, accounting for 70.8% of total sales, equivalent to $52.01M. Another important revenue stream is Mobile Health Services. Understanding this composition is critical for investors evaluating how DCGO navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, DocGo Inc. maintains a gross margin of 26.85%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -24.41%, while the net margin is -24.50%. These profitability ratios, combined with a Return on Equity (ROE) of -92.44%, provide a clear picture of how effectively DCGO converts its operational activities into shareholder value.

In the context of the broader market, DCGO competes directly with industry leaders such as RADX and MBAI. With a market capitalization of $24.49M, it holds a significant position in the sector. When comparing efficiency, DCGO's gross margin of 26.85% stands against RADX's -90.30% and MBAI's N/A. Such benchmarking helps identify whether DocGo Inc. is trading at a premium or discount relative to its financial performance.

DocGo's revenue for Q2 2026 was $73.42 million, down from $80.42 million in Q2 2025, showing a decline in performance. The gross margin has also decreased to 26.85% in Q2 2026, down from 30.77% in Q4 2024, indicating deteriorating profitability.